ClinicalTrials.gg
CompletedNCT04394507Updated May 19, 2020

Lymphatic Function in Patients With a Fontan Circulation From Brazil

An observational study in Univentricular Heart, Lymphatic Abnormalities and Lymphatic Edema, sponsored by University of Aarhus. Completed at 2 sites in Denmark. Open to participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-05-19.

Sponsored by University of Aarhus · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
48
Ages
16 Years and older
Sex
All
01

Study summary

It is suggested that the elevated central venous pressure in patients with a Fontan circulation can provoke manifestation of lymphatic dysfunction, met as plastic bronchitis, peripheral oedema and most feared protein-losing enteropathy (PLE).

An explorative study from our department at Aarhus University Hospital revealed that the function of the lymphatic vasculature in 10 young Fontan patients with no complications was abnormal compared to healthy controls. However, to further describe and confirm these findings we had to investigate the lymphatic circulation in a larger, older and more complicated group of Fontan patients.

The hypothesis is that, patients with a univentricular circulation have a reduced functionality of the lymphatic vasculature and which predisposes them to developing complications such as edema and PLE.

Read the detailed description

The study population is patients with a Fontan circulation followed at InCor Heart Institute in Sao Paolo and Ribeirão Preto, Brazil. These were matched with and group of healthy controls.

The functional state of superficial lymphatics in the lower leg will be investigated, using near infrared fluorescence (NIRF) imaging. The capillary filtration of fluid and leakiness of the capillaries will be measured using strain gauge plethysmography and the peripheral blood flow will be measured using venous occlusion plethysmography. Furthermore, plasma concentration of noradrenaline will be estimated.

02

Conditions studied

  • Univentricular Heart
  • Lymphatic Abnormalities
  • Lymphatic Edema

Keywords

  • Lymphatic dysfunction
  • Near-Infrared Fluorescence Imaging
  • Fontan Circulation
  • Plethysmography
03

In context

Univentricular Heart

86 studies on the registry are indexed under Univentricular Heart; 22 are open to participants now.

This study's enrollment of 48 is above the median of 42 across 37 observational studies indexed under Univentricular Heart.

Browse Univentricular Heart studies →

Lead sponsor

University of Aarhus is the lead sponsor of 1,300 studies on the registry; 189 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients born with a univentricular heart treated surgically with a Fontan circulation in early childhood.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Fontan circulation
  • Age above 16.

Exclusion criteria

Exclusion Criteria:

  • Mental illness
  • Syndromes.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
48 participants (actual)
Patient registry
No

Groups and cohorts

  • Fontan Patients

    Fontan patients operated at the two centres between 1991 and 2014.

    Diagnostic Test: Near-Infrared Fluorescence imaging · Diagnostic Test: Strain Gauge Plethysmography

  • Control Group

    Age, gender and weight matched healthy controls.

    Diagnostic Test: Near-Infrared Fluorescence imaging · Diagnostic Test: Strain Gauge Plethysmography

Interventions

  • Diagnostic testNear-Infrared Fluorescence imaging

    .Near-infrared imaging was used to evaluate the function of the superficial lymphatic vessels in the right lower leg and foot as previously described.doi: 10.1161/CIRCIMAGING.118.008074.

  • Diagnostic testStrain Gauge Plethysmography

    Strain Gauge Plethysmography to asses capillary filtration rate og the lower limb

06

What researchers measure

Primary outcomes

  1. Lymphatic function assessed by Near-Infrared fluorescence Imaging 1

    Contraction frequency (contraction/minut)

    Time frame: 1 hour

  2. Lymphatic function assessed by Near-Infrared fluorescence Imaging 2

    Pumping Pressure (mmHg)

    Time frame: 1 hour

  3. Lymphatic function assessed by Near-Infrared fluorescence Imaging 3

    Packet Velocity

    Time frame: 1 hour

Secondary outcomes

  1. Capillary Filtration Rate measured by Strain Gauge Plethysmography

    Capillary Filtration Rate

    Time frame: 1 hour

07

Study locations

2 sites
  • Aarhus University Hospital
    Aarhus N, Central Denmark Region 8200, Denmark
  • Aarhus University
    Aarhus C, Danmark 8000, Denmark
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2018 to primary completion in Sep 2018, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
May 14, 2020
First posted
May 19, 2020
StartActual
Jul 1, 2018
Primary completionActual
Sep 1, 2018
CompletionActual
May 1, 2019
Last update
May 19, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 19, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04394507
Collaborators
InCor Heart Institute, Hospital das Clínicas de Ribeirão Preto, Rigshospitalet, Denmark
Responsible party
Sponsor
First posted
May 19, 2020
Start date
Jul 1, 2018
Primary completion
Sep 1, 2018
Completion
May 1, 2019
Last update
May 19, 2020

Study contacts

Vibeke Hjortdal, MD, PhD, Dmsc
study director · Rigshospitalet, Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion